Related Experiment Video
Updated: Jun 4, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
[Treatment of writer's cramp with botulotoxin А]
Abstract:
The article presents the analysis and description of clinical manifestation of writer's cramp detected in 21 patients living in Belarus. Clinical variants of disease, possible methods of treatment are discussed. The method for effective treatment of writer's cramp by an injection of botulotoxin type А with sonography is described. Patients with writer's cramp have undergone sonographic analysis of the forearm soft tissues in the area of supposed injection before the procedure of botulotoxin A introduction. Nerves and vessels position, subcutaneous fat and forearm muscles, thickness of points of an injection, have been determined. For objective assessment of qualities of treatment was used Burke-Fahn-Marsden scale.
More Related Videos
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Related Concept Videos
Botulism
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Tetanus
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...